Industry reawakens as more normal business ramps up

Manufacturers are slowly adjusting to another new normal as global business ramps up as Covid-19 restrictions are gradually eased. Geelong wheel manufacturer Carbon Revolution today reported its global customers were resuming production and were calling for normal wheel supply to resume. The company told investors that Ferrari restarted production early this month and had now…

Details

Austal’s USS Oakland completes acceptance trials

The future USS Oakland (pictured) the 12th littoral combat ship built for the US Navy by international shipbuilder Austal has completed its acceptance trials. Austal chief executive David Singleton said the completion of the trials during the Covid-19 pandemic demonstrated the company’s capability and reliability under challenging conditions. He said: “Austal USA has clearly answered…

Details

A new deal plan for manufacturing – countdown to launch

We are on the countdown to the launch of the Australian Manufacturing Forum and @AuManufacturing new deal plan for manufacturing. The plan, crowd sourced from readers and Forum members, will be released on Monday and available for download through @AuManufacturing news. We received close to 50 substantial submissions, numerous emails and phone calls, and hundreds…

Details

RUAG awarded Sovereign Industrial Capability Priority Grant

RUAG Australia has been awarded a Defence grant to grow its capacity and supply chain resilience to support Defence and sustainment of aircraft. The Sovereign Industrial Capability Priority (SICP) grant will enhance efficiency and competitiveness of the company through modernising and automating capital equipment. It will also go towards aid capabilities in the manufacturing and…

Details

Imagion’s breakthrough cancer device in manufacturing milestone

Australian listed medical imaging company Imagion Biosystems has moved a step closer to trialing its breakthrough cancer detection device, with the first phase of manufacture of a nanoparticle formulation completed despite the Covid-19 pandemic. Manufacture of the company’s MagSense HER2 nanoparticle formulation proceeded uninterrupted by the pandemic under good manufacturing practice (GMP) conditions. The second…

Details